The neurokinin-1 receptor antagonist aprepitant, a new drug for the treatment of hematological malignancies: Focus on acute myeloid leukemia

  1. Muñoz, M.
  2. Coveñas, R.
Aldizkaria:
Journal of Clinical Medicine

ISSN: 2077-0383

Argitalpen urtea: 2020

Alea: 9

Zenbakia: 6

Mota: Berrikuspena

DOI: 10.3390/JCM9061659 GOOGLE SCHOLAR lock_openSarbide irekia editor